Brought to you by:
Powered by wagescape.com
Labor Market Pulse
Burlington-South Burlington, VT Metro Edition
Focus: LIFE SCI
2.3%
Chittenden County unemployment
vs 2.6% Vermont statewide, Sept 2026
-1.8%
Chittenden employment change
YoY through Q1 2026, 345th of 371 large US counties
$144,071
Biostatistician advertised pay, metro
down significantly vs $133,322 national (up)
$1,521
Avg weekly wage, Chittenden County
up 3.4% YoY, ranks 121st nationally
This Month's Takeaways
Metro Biostatistician advertised pay dropped significantly even as national median rose to $133,322, a divergence that may signal Burlington employers are losing bidding power for data science talent against remote-friendly national postings. Compensation strategy built on local comparables alone risks understating true retention risk for this function.
Chittenden County's workforce housing shortfall, with no meaningful supply relief expected until 2027–28, raises effective cost of living faster than advertised pay is moving. Relocation packages and total rewards framing may need to absorb housing friction directly to keep offers competitive for out-of-state scientific hires.
Rocket Pharma's Winooski CMC regulatory posting at $204K–$264K, against a national VP Regulatory Affairs range of $320K–$580K, shows Burlington employers can source mid-level regulatory talent below national premiums, but only for roles short of top-tier BLA/NDA experience. Leaders needing first-in-class regulatory leadership should expect to compete on national terms, not local ones.
Metro Clinical Data Manager pay fell sharply while national pay also softened moderately, a pattern more consistent with employers narrowing role requirements than with weakening demand for data management expertise. Compensation benchmarking should separate falling advertised pay from falling headcount need before adjusting offer bands.
Local Labor Conditions
Chittenden County unemployment held near 2.3% in September while county employment fell 1.8% year-over-year through Q1 2026, a combination that signals structural labor scarcity rather than cyclical slack. Vermont's shrinking labor force, driven by retirements and limited new entrants, compounds the squeeze on credentialed scientific, regulatory, and manufacturing talent that biotech and med device employers in the metro depend on.
Leadership & Talent Implications
Falling Clinical Data Manager and Biostatistician advertised pay locally, even as Biostatistician pay rises nationally, suggests Burlington employers are either narrowing scope on these roles or losing wage competitiveness against larger biopharma hubs actively recruiting the same talent pool. With Rocket Pharma's Winooski Director of Regulatory Affairs–CMC posting at $204K–$264K and regional CDMO/CRO capacity available through Charles River East Thetford, leaders face a sharper build-versus-outsource calculus for specialized regulatory and quality functions than a quiet headline unemployment rate would imply. Consider reviewing whether current advertised pay for data and biostatistics roles reflects genuine local scarcity or a risk of losing candidates to national remote-eligible postings.
Advertised Pay Indicators
| Role | P25 | Median | P75 | Local Trend | National | Nat. Trend |
|---|---|---|---|---|---|---|
| Research Scientist | — | — | — | — No data | $131,354 | ↑ Significant increase |
| Clinical Research Associate | $68,631 | $69,108 | $69,108 | → Stable | $90,956 | ↑ Significant increase |
| Lab Technician | $36,655 | $39,520 | $41,282 | ↓ Significant decline | $47,402 | ↓ Moderate decline |
| Regulatory Affairs Specialist | $86,099 | $95,902 | $100,000 | → Stable | $104,000 | → Stable |
| Clinical Data Manager | $83,968 | $107,599 | $111,352 | ↓ Significant decline | $123,031 | ↓ Moderate decline |
| Biostatistician | $103,584 | $144,071 | $144,343 | ↓ Significant decline | $133,322 | ↑ Moderate increase |
| Validation Engineer | — | — | — | — No data | $108,377 | ↑ Moderate increase |
Some roles reflect state-level data where local metro sample size was insufficient.
Looking Ahead · Next 30–60 Days
Potential inflection point
November's Right to Collective Bargaining ballot measure carries roughly 65% polling support; a favorable outcome could reshape unionization dynamics for manufacturing and R&D technician roles at Vermont life sci employers over the following year.
Emerging pressure point
UVM Health Network's WARN-driven impact lands in October, following earlier 142-worker notices in June. Watch whether displaced clinical and research-adjacent talent enters the regional candidate pool in numbers meaningful for quality and clinical support hiring.
Worth watching
Chittenden County employment has declined for multiple consecutive quarters despite sub-2.5% unemployment, an unusual pairing that warrants tracking against statewide labor force contraction when planning headcount growth for 2027.
Early indicator
National September layoff activity at BioMarin and Bristol Myers coexists with 64% of surveyed biopharma firms still actively recruiting. Monitor whether any released talent, particularly in CMC or regulatory functions, surfaces in Vermont-based postings or relocations.
WageScape Member Benefit
Your Pulse covers one metro and one function or industry. Add coverage if you want to see the latest intelligence for other markets, industries, or functions.
Pulse Plus
3 metro reports
$149/year
Pulse Pro
10 metro reports
$349/year
Enterprise
10+ markets
Contact us
WageTrak · 15% Member Discount
On-demand advertised pay data across thousands of job titles, all metro areas, full percentile coverage, and monthly updates. Use code WAGESCAPE15 at wagetrak.com.
Forwarded This Briefing?
Receive your own personalized monthly briefing, filtered to your local market. Scan to enroll below.